NTLA vs IE Comparison

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Ivanhoe Electric Inc is a United States-based minerals exploration and development company with a focus on developing mines from mineral deposits located in the United States. The company has three reportable segments; Critical metals segment is focused on mineral project exploration and development with a focus on identifying and developing mineral projects, and ultimately mines, associated with the metals necessary for electrification, The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas and water exploration industries, and The energy storage segment develops, manufactures and installs vanadium flow batteries for grid-scale energy storage. It derives a majority of its revenue from Canada.